Emergency Medicine Doctors in Belfast, ME Accepting Medicare

7 Emergency Medicine doctors found. Showing 1 - 7

Camille C Canova, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500    Fax: 207-338-9380

Mr. Elmo Glenn Tucker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-9324    Fax: 207-338-6820

Douglas Kent Clark, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500    Fax: 207-338-9380

John D Gage, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500    Fax: 207-338-9380

Linda K Tyer, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500    Fax: 207-930-2550

Dr. Rishi D Ramkissoon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500    Fax: 207-338-9380

Dr. Daniel J Britton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-505-4123

News Archive

Pancreatitis drug Nafamostat shows promise for coronavirus

With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.

Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast cancer

Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.

Hologic receives FDA voting for 3-D digital mammography system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced that the Radiological Devices Panel (Panel) of the U.S. Food and Drug Administration (FDA) today unanimously voted that Hologic's Pre-Market Approval (PMA) demonstrated both the effectiveness and safety of the Company's Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system, "Selenia Dimensions 3-D."

Researchers use SIG-Blocks for cognitive testing and training of adults and children

Psychologists have long used building blocks to assess cognitive skills. But researchers at Case Western Reserve University are imbedding the blocks with technology that may provide a clearer view of problems a child or adult may suffer due to developmental disabilities, brain trauma or dementia.

BDSI prices $15 million private placement

BioDelivery Sciences International, Inc. announces that it has received definitive commitments from institutional investors for a private placement financing yielding gross proceeds of $15 million to BDSI. The financing is expected to close today.

Read more Medical News

› Verified 9 days ago